No concerns about Medtronic, Otsuka BP devices raised by USFDA staff Ruchika Sharma21 Aug 2023 2:30 PM ISTThe staff reviewers said the available safety data for the device made by ReCor, a unit of Otsuka Holdings, did not raise concerns, while pointing...
Regeneron Pharma Eylea HD injection approved by USFDA for treatment of Wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy Ruchika Sharma21 Aug 2023 1:30 PM ISTTarrytown: Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD...
NIPERs to become world class research institutes by establishing Centres of Excellence, creating a talent pool of qualified and trained students Ruchika Sharma21 Aug 2023 12:40 PM ISTNew Delhi: Union Minister of Health and Family Welfare and Chemicals and Fertilizers, Dr Mansukh Mandaviya accompanied the G-20 Ministers and...
Medicines manufactured in India saves lives in Netherlands, Europe, across world: Netherlands Health Minister Ruchika Sharma21 Aug 2023 11:30 AM ISTDr Mandaviya leads G20 delegation on a visit to Jan Aushadhi Kendras.
Ajanta Pharma Gets CDSCO panel conditional Nod to Manufacture, Market Cardiovascular FDC Drug Dr. Divya Colin20 Aug 2023 5:30 PM ISTNew Delhi: Citing that the proposed FDC is already approved in higher strength, the Subject Expert Committee (SEC) functional under the Central Drug...
AbbVie gets European Commission nod for Aquipta for prophylaxis of migraine in adults Ruchika Sharma20 Aug 2023 3:00 PM ISTNorth Chicago: AbbVie has announced that the European Commission has approved AQUIPTA (atogepant) for the prophylaxis of migraine in adults...
AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure Ruchika Sharma20 Aug 2023 1:30 PM ISTForxiga is a first-in-class, oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2).
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
Boehringer Ingelheim to advance Survodutide into 3 global Phase III studies in obesity Ruchika Sharma20 Aug 2023 10:00 AM ISTGermany: Boehringer Ingelheim has announced it will advance survodutide, its glucagon/GLP-1 receptor dual agonist, into three registrational Phase III...
Merck declares topline results from Phase 3 trial of Welirag Ruchika Sharma19 Aug 2023 4:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced topline results from LITESPARK-005, the first positive Phase 3...
Concord Biotech up 33 percent in debut, nets over USD 1 billion in valuation Ruchika Sharma19 Aug 2023 3:39 PM ISTBengaluru: Shares of India's Concord Biotech climbed as much as 33.3 per cent in their market debut on Friday, valuing the biopharma company at more...
Lupin buys diabetes brands Ondero, Ondero Met from Boehringer Ingelheim International for Rs 235 Crore Ruchika Sharma19 Aug 2023 2:27 PM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of diabetes brands ONDERO and ONDERO MET, from Boehringer Ingelheim...
